Beware Of These Post-COVID-19 Symptoms, Warn WHO Experts
WHO Regional Director for Europe Hans Kluge expresses health concerns over "long-Covid" or "post-Covid". Read on to know more.
WHO Regional Director for Europe Hans Kluge expresses health concerns over "long-Covid" or "post-Covid". Read on to know more.
FuG1 interfered with the overall stability of the SARS-CoV-2 spike protein, which in general is necessary for infecting cells and transmissibility of the virus.
Farah Khan had already received two vaccine shots against COVID-19. Don't let your guard down. The virus is still here and some strains are less sensitive to vaccine antibodies.
Many COVID-19 symptoms bear no resemblance to normal indicators of respiratory ailments. Now researchers say it is actually a vascular ailment.
Vector-borne diseases can become rampant during the monsoons. Neglecting the preventive control measures can lead to a spike in the numbers and leave the health system overburdened amidst the COVID-19 pandemic.
Still reeling under the devastating second wave of the COVID-19 pandemic, Delhi gets ready to fight the third wave that is likely to target children more.
In the UK, experts have noticed that South Asians are more at risk of getting infected with the COVID-19 virus and also at like to suffer severe complications.
Many patients experience debilitating symptoms even after recovery from COVID-19. A new study claims to have identified the reasons for this.
Persistent infections in immunocompromised people may cause the COVID-19 virus to mutate more frequently. Read on for more details.
Pfizer has started Phase 1 clinical trial of a novel oral antiviral drug for treatment of COVID-19. Meanwhile, Hong Kong and Macau on Wednesday suspended the use of Pfizer/BioNTech's COVID-19 vaccine after defective bottle lids were found in one batch of vials.
US coronavirus model forecasts new variants may drive up the COVID-19 death toll. Read on to know more.
A new US study has found that patients who had recovered from COVID-19 have immune memory to SARS-CoV-2 for up to 8 months after symptoms appeared.
WHO Regional Director for Europe Hans Kluge expresses health concerns over "long-Covid" or "post-Covid". Read on to know more.
FuG1 interfered with the overall stability of the SARS-CoV-2 spike protein, which in general is necessary for infecting cells and transmissibility of the virus.
Farah Khan had already received two vaccine shots against COVID-19. Don't let your guard down. The virus is still here and some strains are less sensitive to vaccine antibodies.
Many COVID-19 symptoms bear no resemblance to normal indicators of respiratory ailments. Now researchers say it is actually a vascular ailment.
Vector-borne diseases can become rampant during the monsoons. Neglecting the preventive control measures can lead to a spike in the numbers and leave the health system overburdened amidst the COVID-19 pandemic.
Still reeling under the devastating second wave of the COVID-19 pandemic, Delhi gets ready to fight the third wave that is likely to target children more.
In the UK, experts have noticed that South Asians are more at risk of getting infected with the COVID-19 virus and also at like to suffer severe complications.
Many patients experience debilitating symptoms even after recovery from COVID-19. A new study claims to have identified the reasons for this.
Persistent infections in immunocompromised people may cause the COVID-19 virus to mutate more frequently. Read on for more details.
Pfizer has started Phase 1 clinical trial of a novel oral antiviral drug for treatment of COVID-19. Meanwhile, Hong Kong and Macau on Wednesday suspended the use of Pfizer/BioNTech's COVID-19 vaccine after defective bottle lids were found in one batch of vials.
US coronavirus model forecasts new variants may drive up the COVID-19 death toll. Read on to know more.
A new US study has found that patients who had recovered from COVID-19 have immune memory to SARS-CoV-2 for up to 8 months after symptoms appeared.
Don’t Miss Out on the Latest Updates.
Subscribe to Our Newsletter Today!
